Columbia University Health Sciences

  • Columbia University

    The mission of the Irving Institute for Clinical and Translational Research is to advance discoveries, knowledge, and innovation to improve human health across the lifespan for diverse populations in upper Manhattan and around the world. By mobilizing and connecting Columbia University’s researchers, we aim to create a seamless integration of community and academic partnerships. Our commitment to train a multi-faceted workforce, provide vital resources to researchers, and improve the efficiency of research processes, promotes the collaborative team science framework needed to translate research discoveries into effective interventions that address current and future health concerns.

    We provide over 70 different services and programs focused on education and training, seed funding, bioinformatics, biostatistics, clinical research, lifespan research and special populations, regulatory knowledge and bioethics, an off-site community facility and health informatics websites.
  • An excerpt from the Narratives of Discovery article with Rita Charon and Henry Colecraft: The hypothesis comes first. If the artist’s aesthetic production is the painting or the novel, the scientist’s aesthetic production is not the scientific conclusion. It is the hypothesis. I asked Henry what it takes for the scientist to imagine, like Huxley did, a reality before it can be seen: "I think it's

  • Columbia University Health Sciences

    Minoritized communities face multiple barriers to clinical trial participation. Columbia University’s Irving Institute for Clinical and Translational Research and the Herbert Irving Comprehensive Cancer Center in partnership with New York Presbyterian Hospital, local non-profits, community-based physicians and lay health workers, seek to address individual, provider, and institutional barriers to

  • Two projects have been given the green light to explore new technology and practices that have the potential to save lives and reduce health care inequity through the Irving Institute for Clinical and Translational Research’s Strategic Priorities Pilot Award – Learning Health System. A collaboration with the Columbia University Learning Health System initiative, the Columbia University Irving

  • An excerpt from David Ho and Rita Charon Narrative Interview 2022: Overcoming translational science barriers. David’s reflections illuminate potential barriers to progress in translational science—the grip of dogma and the challenge of living up to science’s ethical mission: The grip of dogma: In the early days of HIV/AIDS research, David suffered persistent criticism from colleagues and superiors

  • University Of Colorado Denver
    Columbia University Health Sciences
    University Of North Carolina Chapel Hill

    What is the CTSA Compendium of D&I Catalogs?

  • The Columbia University CTSA is proud to present this year’s Honorary Leahey Lecture Series, as part of the Medicine Grand Rounds David Kessler, MD Chief Science Officer for COVID Response for the administration of President Joe Biden A moderated discussion between Dr. Kessler and Dr. Magda Sobieszczyk: Dr. Kessler has been spearheading the vaccine and therapeutics initiatives for the White House

  • Columbia University Health Sciences

    To learn of the creative springs of today's science, Dr. Rita Charon interviews leading scientists, for the US National Institutes of Health (NIH) Narratives of Discovery project. She draws on their thoughts, imagination and analytical minds to illuminate the interconnections among the modes of knowing, seeing, and telling in the medical sciences. The fifth article in the series is now published

  • Columbia University Health Sciences

    The Irving Institute for Clinical and Translational Research (IICTR), home to Columbia University’s CTSA Program Hub, supports a mission of bringing novel innovations to patients through education, mentorship and pilot award funding through the Accelerate program. The Accelerate program leverages Columbia University’s proficiency in drug discovery and provides access to entrepreneurs and industry

  • The grant, awarded by the National Institutes of Health, is one of the largest ever to the medical school. It will support the work of the Irving Institute for Clinical and Translational Research, led by Muredach Reilly, MBBCh, MSCE, professor of medicine and associate dean for clinical and translational research. The Institute works in partnership with researchers and clinicians across Columbia

  • Columbia University Health Sciences

    Learning the Ropes - Irving Institute’s Translational Therapeutics Accelerator (TRx) Helps Researchers Navigate the Challenges of Commercialization

  • A discussion with Andrea Califano and narrative medicine writer, Rita Charon: Art and science unfold in time as chronological sightings overturn until-then received knowledge—from the epic to the novel, from classical portraiture to cubism, from before Copernicus to after Copernicus. Art and science unfold in space as discoverers choose a scale and a scope—from parole to langue, from harmony to

  • Columbia University Health Sciences

    This course has been recorded and the full video series is now available online. Taught via Zoom at Columbia University, Fall 2020. Intellectual property (patents, copyrights, trademarks) are an increasingly critical part of almost any business, at almost any stage of growth. This course provides the aspiring business executive, entrepreneur, or scientist an overview of commercial opportunities

  • The Irving Institute for Clinical and Translational Research, Columbia University's CTSA Hub, has partnered with Rita Charon on a new narrative medicine series, interviewing today’s leading life scientists. "The effective practice of medicine requires narrative competence, that is, the ability to acknowledge, absorb, interpret, and act on the stories and plights of others. Medicine practiced with

  • The Irving Institute for Clinical and Translational Research, home of the Columbia University CTSA Hub, is offering - TL1 Training Program Now Accepting Applications The TL1 Training Programs are intended to provide trainees with additional research training to prepare for a research career that can contribute in some meaningful way to understanding risk of disease, improving diagnosis and

  • The Irving Institute's Columbia Community Partnership for Health (CCPH), in partnership with the NYP Emergency Food Program, has been delivering groceries in upper Manhattan to 890 families each month during the COVID-19 pandemic. Watch the amazing community effort and impact that has resulted:

  • North American Mitochondrial Disease Consortium (NAMDC)

    Mitochondrial diseases affect approximately 1 in every 5,000 people. These diseases can cause muscle weakness, difficulty thinking, seizures, hearing and vision loss, digestive problems, learning disabilities, and organ failure. The North American Mitochondrial Disease Consortium (NAMDC) is a network of clinicians and researchers at 17 different clinical sites working to better understand

  • Nephrotic Syndrome Rare Disease Clinical Research Network III (NEPTUNE)

    Focal and Segmental Glomerulosclerosis, Minimal Change Disease, and Membranous Nephropathy, presenting as Nephrotic Syndrome (NS), are a group of rare renal diseases that may cause serious complications and end-stage kidney disease, generating significant individual, societal and economic burdens. The Nephrotic Syndrome Study Network (NEPTUNE) brings together physician scientists at 26 sites in

  • The Columbia University CTSA KL2 program is honored to be highlighted as one of the top program hubs by the Center for Leading Innovation and Collaboration (CLIC). The CU program has demonstrated significant improvements in the Careers in Clinical & Translational Research Common Metric within the KL2 women’s measure. The CLIC Common Metrics Initiative team collects and reports annual data, and

  • Columbia University Health Sciences
    Columbia University CTSA Program Hub Innovations:​ Operating a Clinical Research Unit in the COVID-19 Era and Building a COVID-19 Biobank​ Heather Seid, MS, RDN (1); Sheila O’Byrne, PhD (2); Elisabeth DiMaria, MHA (1); Ismael Castaneda, MS, BSN (1); Dianne Frederick (1); Janelle Nunez (1); Ariella Kelin, MSRN (3); Josh Wansley, MSRN (3); Danielle Pendrick, DrPH (4); Jennifer Williamson, MS, MPH (5
  • We’re thrilled to join forces with @HHPHorg for #20SegundosOMas Together with Olajide Williams, the President and Founder of Hip Hop for Health, and faculty of the Columbia University CTSA Hub, this PSA features over 30 community influencers and activists who represent the full depth, breadth and diversity of the Latino diaspora. In just a few hours it had already reached an audience of more than

  • Drawing of a network on a global

    The New York and Connecticut Consortium encourages joint ventures among the New York and Connecticut area CTSA institutions (NYCON) to develop collaboration between CTSA programs in the areas of medical scientist training; the creation of regional databases of facilities; regional training opportunities for investigators and research coordinators; the exploration of barriers to improved social

  • CD2H-teal
    Columbia University Health Sciences

    These stand-alone workshops precede the May 6th-7th conference for best practices in representation & reasoning. The workshops have separate calls for papers and their own program and organizing committee. The tutorials are half-day learning sessions that include both lecture style and hands-on sessions. Early bird registration ends Feb 15, 2020!

  • Precision medicine has arrived, but many physicians do not have the training or time to incorporate genetic sequencing technologies into everyday practice. In two new articles published online in the Annals of Internal Medicine, precision medicine experts at Columbia University Vagelos College of Physicians and Surgeons and Co-Directors of the Irving Institute’s Precision Medicine Resource, Drs

  • A genomic incompatibility could explain why many kidney transplants fail, even when donors and recipients are thought to be well-matched, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons suggests. The co-senior author is Dr. Krzysztof Kiryluk, Herbert Irving Assistant Professor of Medicine and Co-Director of the Irving Institute’s Precision Medicine

  • Columbia University Health Sciences
    The Columbia Lab-to-Market: Life Science Accelerator Program comprised of the Translational Therapeutics Accelerator (TRx), Accelerating Cancer Therapeutics (ACT), and the Biomedical Technology Accelerator (BiomedX). About the Course: This course is a series of evening sessions designed to provide specialized frameworks and essential tools to investigator teams (clinicians, engineers, scientists)
  • Columbia University Fall 2019 Poster
    Columbia University Health Sciences

    The Irving Institute for Clinical and Translational Research, home to Columbia University’s CTSA Program Hub, provides resources to investigators in the areas of precision medicine and translational research through two unique resources focused on providing funding, education, research services, and mentorship programs to support advancement of projects. The Translational Therapeutics (TRx)